Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-20-017836)

Filing Details

Accession Number:: 0001209191-20-017836
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-03-10 18:12:56
Reporting Period:: 2020-03-09

Accepted Time:: 2020-03-10 18:12:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1253689	Glycomimetics Inc	GLYC	()	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1094159	M Daniel Junius	C/O Glycomimetics, Inc. 9708 Medical Center Drive Rockville MD 20850		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-03-09	20,000	$3.40	38,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The Reporting Person purchased the securities on the open market at purchase prices ranging from $3.40 to $3.41 per share, with a weighted average purchase price of $3.40 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.